111 – 120 of 150
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The role of PEDF in pancreatic cancer
- Contribution to journal › Scientific review
-
Mark
The hippo signaling pathway in pancreatic cancer
- Contribution to journal › Scientific review
-
Mark
Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis
- Contribution to journal › Article
-
Mark
Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics
- Contribution to journal › Article
-
Mark
Proteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone
- Contribution to journal › Article
-
Mark
Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease
- Contribution to journal › Article
-
Mark
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
- Contribution to journal › Article
-
Mark
Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
- Contribution to journal › Article
-
Mark
Clinical protein science in translational medicine targeting malignant melanoma
- Contribution to journal › Article
-
Mark
Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma
- Contribution to journal › Article
